| 发明名称 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS C VIRUS INFECTIOUS DISEASE |
| 摘要 |
The present invention relates to a pharmaceutical composition for preventing or treating hepatitis C virus (HCV) infectious disease. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating HCV infectious disease or an antiviral composition for HCV, containing at least one selected from the group consisting of: GRIM19 protein or a fragment thereof; and a gene encoding the protein or a fragment of the protein. |
| 申请公布号 |
US2016271229(A1) |
申请公布日期 |
2016.09.22 |
| 申请号 |
US201415032717 |
申请日期 |
2014.10.28 |
| 申请人 |
THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
发明人 |
YOON Seung Kew;KIM Jung Hee;HUR Won Hee;CHO Mi La;CHOI Jung Eun;LEE Eun Byul |
| 分类号 |
A61K38/44;C12N15/113;A61K31/7088;A61K31/155;A61K31/196;A61K39/395;A61K31/7072;A61K38/17;C12N15/115 |
主分类号 |
A61K38/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition for preventing or treating a hepatitis C virus infectious disease, comprising at least one selected from the group consisting of genes-associated with Reinoid-Interferon induced Morality 19 (GRIM19) protein or a fragment thereof, and a gene encoding the protein or the fragment thereof. |
| 地址 |
Seocho-gu Seoul KR |
